November 7, 2017 / 12:23 PM / 15 days ago

BRIEF-Aclaris Therapeutics says qtrly loss per share $0.63

Nov 7 (Reuters) - Aclaris Therapeutics Inc-

* Aclaris Therapeutics reports third quarter 2017 financial results

* Aclaris Therapeutics Inc - qtrly loss per share $0.63

* Aclaris Therapeutics Inc - qtrly revenue of $684,000

* Aclaris Therapeutics Inc- ‍cash burn for 2017 is now estimated to be in range of $56 million to $59 million​

* Aclaris Therapeutics Inc- ‍research and development expenses for 2017 are now estimated to be in range of $39 million to $42 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below